Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study

References

• UK Health & Safety Executive. Better backs. http://www.hse. gov.uk/betterbacks/indexb.htm [last accessed 12 August 2005]
   Google Scholar
• Andersson G. Epidemiological features of chronic low back pain. Lancet 1999;354:581–5
   PubMed Web of Science ®Google Scholar
• Bener A, El-Rufaie OF, Siyam A, et al. Epidemiology of low back pain in the United Arab Emirates. APLAR J Rheumatol 2004;7:189–95
   Google Scholar
• Seitz R, Schweikert B, Jacobi E, et al. Economic rehabilitation management among patients with chronic low back pain. Schmerz 2001;15:448–52 [German]
   Google Scholar
• Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646–56
   PubMed Web of Science ®Google Scholar
• Walker BF, Muller R, Grant WD. Low back pain in Australian adults. The economic burden. Asia Pac J Publ Health 2003; 15:79–87
   PubMedGoogle Scholar
• Skouen JS, Grasdal AL, Haldorsen EM, et al. Relative cost of extensive and light multidisciplinary treatment programs versus treatment as usual for patients with chronic low back pain on long-term sick leave: randomized controlled study. Spine 2002;27:901–9
   PubMed Web of Science ®Google Scholar
• Hansson TH, Hansson EK. The effects of common medical interventions on pain, back function, and work resumption in patients with chronic low back pain: a prospective 2-year cohort study in six countries. Spine 2000;25:3055–64
   PubMed Web of Science ®Google Scholar
• Lin MR, Tsauo JY, Wang JD. Determinants of economic cost related to low back pain among nurses at a university hospital. Int J Occup Environ Health 1996;2:257–63
   Google Scholar
• Lovanyi I. Analysis of pathological and non-pathological human motion using 3D motion capture methods. www.nkth.gov.hu/ letolt/k+f/kf_angol/elements/PDF/IKTA4–138-AnalysisOfPath ologicalAndNonpathological-Lovanyi.pdf [last accessed 26 July 2005]
   Google Scholar
• Stewart WF, Ricci JA, Chee E, et al. Lost productive time and cost due to common pain conditions in the US workforce. J Am Med Assoc 2003;290:2443–54
   PubMed Web of Science ®Google Scholar
• Margarido MS, Kowalski SC, Natour J, et al. Acute low back pain: diagnostic and therapeutic practices reported by Brazilian rheumatologists. Spine 2005;30:567–71
   PubMed Web of Science ®Google Scholar
• Chronic back injury. www.arthritis.ca/types%20of%20arthritis/ chronicback/default.asp [last accessed 12 August 2005]
   Google Scholar
• Shekelle PG, Delitto AM. Treating low back pain. Lancet 2005;365:1987–90
   PubMed Web of Science ®Google Scholar
• Pincus T, Burton AK, Vogel S, et al. A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain. Spine 2002;27:E109–20
   PubMedGoogle Scholar
• Koes BW. Surgery versus intensive rehabilitation programmes for chronic low back pain. Br Med J 2005;330:1220–1
   PubMed Web of Science ®Google Scholar
• Fairbank J, Frost H, Wilson-MacDonald J, et al.; for the Spine Stabilisation Trial Group. Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trial. Br Med J 2005;330:1233–8
   Google Scholar
• Cherkin DC, Devo RA, Wheeler K, et al. Physician variation in diagnostic testing for low back pain. Who you see is what you get. Arthritis Rheum 1994;37:15–32
   Web of Science ®Google Scholar
• Zanoli G, Stromqvist B, Jonsson B, et al. Pain in low-back pain. Problems in measuring outcomes in musculoskeletal disorders. Acta Orthop Scand Suppl 2002;73:54–7
   PubMedGoogle Scholar
• Deyo RA. Drug therapy for back pain. Which drugs help which patients? Spine 1996;21:2840–9
   Google Scholar
• van Tulder MW, Scholten RJ, Koes BW, et al. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000;25:2501–13
   PubMed Web of Science ®Google Scholar
• Birbara CA, Puopolo AD, Munoz DR, et al.; for the Etoricoxib Protocol 042 Study Group. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability – a randomized, placebo-controlled, 3-month trial. J Pain 2003;4: 307–15
   Google Scholar
• Pallay RM, Seger W, Adler JL, et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 2004;33:257–66
   PubMed Web of Science ®Google Scholar
• Airaksinen O, Brox JI, Cedraschi C, et al.; on behalf of the COST B13 Working Group on Guidelines for Chronic Low Back Pain. European guidelines for the management of chronic non-specific low back pain. http://www.backpaineurope.org/ [last accessed 12 August 2005]
   Google Scholar
• Ramey DR, Watson DJ, Yu C, et al. The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Curr Med Res Opin 2005;21:715–22
   PubMed Web of Science ®Google Scholar
• Anon. Scientific approach to the assessment and management of activity-related spinal disorders. A monograph for clinicians. Report of the Quebec Task Force on Spinal Disorders. Spine 1987;12(7 Suppl):S1–59
   Google Scholar
• Ehrich EW, Davies GM, Watson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635–41
   PubMed Web of Science ®Google Scholar
• Katz N, Ju WD, Krupa DA, et al. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine 2003;28:851–8
   PubMed Web of Science ®Google Scholar
• Matsumoto AK, Melian A, Mandel DR, et al. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. J Rheumatol 2002;29:1623–30
   PubMed Web of Science ®Google Scholar
• Van der Heijde D, Baraf HSB, Ramos-Remus C, et al. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. Arthritis Rheum 2005;52:1205–15
   PubMed Web of Science ®Google Scholar
• Collantes E, Curtis SP, Lee KW, et al. A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. BMC Fam Prac 2002;3:10 [doi:http//www. biomedcentral.com/1471–2296/3/10]
   Google Scholar
• Deyo RA. Treatments for back pain: can we get past trivial effects? Ann Intern Med 2004;141:957–8
   PubMed Web of Science ®Google Scholar
• Salerno SM, Browning R, Jackson JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med 2002;162:19–24
   Google Scholar
• Kominski GF, Heslin KC, Morgenstern H, et al. Economic evaluation of four treatments for low-back pain: results from a randomized controlled trial. Med Care 2005;43:428–35
   PubMed Web of Science ®Google Scholar
• Rivero-Arias O, Campbell H, Gray A, et al. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. Br Med J 2005;330:1239–44
   Google Scholar
• Guzmán J, Esmail R, Karjalainen K, et al. Multidisciplinary rehabilitation for chronic low back pain: systematic review. Br Med J 2001;322:1511–6
   Google Scholar
• Koes BW, Scholten RJPM, Mens JMA, et al. Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials. Ann Rheum Dis 1997;56:214–23
   PubMed Web of Science ®Google Scholar
• Bombardier C. Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations. Spine 2000;25:3100–3
   PubMed Web of Science ®Google Scholar
• Bombardier C, Hayden J, Beaton DE. Minimal clinically important difference. Low back pain: outcome measures. J Rheumatol 2001;28:431–8
   Google Scholar
• Famaey JP, Bruhwyler J, Vandekerckhove K, et al. Open controlled randomised multicenter comparison of nimesulide and diclofenac in the treatment of subacute and chronic low back pain. J Drug Assess 1998;1:349–68
   Google Scholar
• Bombardier C, Laine L, Reicin A, et al.; for the VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520–8
   Google Scholar
• Bresalier RS, Sandler RS, Quan H, et al.; for the Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352: 1092–102
   Google Scholar
• Solomon SD, McMuray JJV, Pfeffer MA, et al.; for the Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352: 1071–80
   Google Scholar
• Farkouh ME, Kirshner H, Harrington RA, et al.; for the TARGET Study Group. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 2004;364:675–8
   Google Scholar
• European Medicine Agency concludes action on COX-2 inhibitors. http://www.emea.eu.int/pdfs/human/press/pr/20776695en.pdf [last accessed 28 August 2005]
   Google Scholar
• Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. Br Med J 2005;330: 1366–72
   Google Scholar
• Juni P, Reichenbach S, Egger M. COX 2 inhibitors, traditional NSAIDs, and the heart. Br Med J 2005;330: 1342–3
   Google Scholar